PMID: 13631508Jan 1, 1959Paper

Structure-activity determinants of pharmacological effects of amino acids and related compounds on central synapses

Journal of Neurochemistry
D P PURPURAH GRUNDFEST

Abstract

No abstract listed.

References

Nov 28, 1955·The Journal of Physiology·E FLOREY, H MCLENNAN
Aug 1, 1956·Electroencephalography and Clinical Neurophysiology·W M LANDAU
Nov 1, 1956·Journal of Neurophysiology·H GRUNDFEST, D P PURPURA
Nov 10, 1956·Nature·A BAZEMOREE FLOREY
Mar 14, 1957·Annals of the New York Academy of Sciences·H GRUNDFEST
Aug 1, 1957·Electroencephalography and Clinical Neurophysiology·D P PURPURAE M HOUSEPIAN
Aug 1, 1957·Proceedings of the Society for Experimental Biology and Medicine·D P PURPURAH GRUNDFEST
Oct 30, 1957·The Journal of Physiology·K IWAMA, H H JASPER
Nov 26, 1957·Acta Physiologica Scandinavica·H ERIKSON
Feb 7, 1958·Science·A S MARRAZZIJ M RODRIGUEZ
Feb 1, 1958·Proceedings of the Society for Experimental Biology and Medicine·D P PURPURAJ A GOMEZ
Mar 7, 1958·Science·W G VAN DER KLOOTI M COOKE
Jun 1, 1955·British Journal of Pharmacology and Chemotherapy·R B BARLOW

❮ Previous
Next ❯

Citations

Nov 1, 1992·Medicinal Research Reviews·D I Kerr, J Ong
Sep 25, 1981·Molecular and Cellular Biochemistry·M J Iadarola, K Gale
Jan 1, 1967·Experimental Brain Research·K Krnjević, S Schwartz
Jan 1, 1969·Experimental Brain Research·J S Kelly, K Krnjević
Nov 1, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·G P SgaragliA Giotti
Oct 1, 1977·Neurochemical Research·B SadasivuduK Murthy
Aug 1, 1961·Comparative Biochemistry and Physiology·E FLOREY, D D CHAPMAN
Feb 1, 1960·Electroencephalography and Clinical Neurophysiology·T G SMITH, D P PURPURA
Feb 1, 1960·Electroencephalography and Clinical Neurophysiology·D P PURPURAH GRUNDFEST
Jun 1, 1961·Electroencephalography and Clinical Neurophysiology·D P PURPURA, E M HOUSEPIAN
Sep 1, 1965·Electroencephalography and Clinical Neurophysiology·S Ochs, H Suzuki
Dec 1, 1965·Electroencephalography and Clinical Neurophysiology·L Berlin, V E Amassian
Sep 1, 1975·Electroencephalography and Clinical Neurophysiology·L K Kaczmarek, W R Adey
Jan 1, 1989·Pharmacology & Therapeutics·Z H Siddik, R A Newman
Dec 1, 1981·Brain Research·E Puil
Dec 1, 1976·General Pharmacology·P A BaileyB S Sastry
Sep 11, 1999·Neurochemistry International·M R Bennett, V J Balcar
Jan 1, 1992·Clinical and Experimental Pharmacology & Physiology·G A Johnston
Nov 1, 1966·Journal of Neurochemistry·H F Bradford, H McIlwain
May 1, 1969·Journal of Neurochemistry·B B Gallagher
Jun 1, 1963·British Journal of Pharmacology and Chemotherapy·N J GIARMAN, K F SCHMIDT
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·J M CRAWFORD, D R CURTIS
Apr 1, 1961·Acta Physiologica Scandinavica·B ANDERSSONF POCCHIARI
Jan 1, 1984·Critical Reviews in Toxicology·P Gross
Sep 1, 1960·Journal of Neurochemistry·D R CURTIS, J C WATKINS
Aug 1, 1961·Journal of Neurochemistry·M RUSCAK
Jun 1, 1961·British Journal of Pharmacology and Chemotherapy·D R CURTISJ C WATKINS
Nov 1, 1961·Experimental Neurology·D P PURPURA, E M HOUSEPIAN

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.